COVID-19 and the flu share so many symptoms that you can’t reliably tell them apart without a test. Both cause fever, cough, body aches, fatigue, and sore throat. But the two illnesses come from entirely different virus families, and they differ in important ways: how quickly they hit, how severely they can damage your body, and what happens in the weeks and months after you recover.
Why the Symptoms Look So Similar
Both viruses infect your respiratory tract and trigger your immune system in overlapping ways, which is why the symptom lists are nearly identical. Fever, chills, cough, congestion, sore throat, muscle aches, headaches, and fatigue show up with both illnesses. Some people with either virus also experience vomiting or diarrhea, though this is more common in children.
The one symptom that leans more toward COVID-19 is a change in or loss of taste and smell. While this can occasionally happen with the flu (any swollen nasal passage can dull your sense of smell), it occurs far more frequently with COVID-19 and sometimes shows up even without significant congestion. That said, it’s not reliable enough on its own to make a diagnosis, especially as newer COVID variants cause it less often than earlier ones did.
Different Timelines From Exposure to Illness
The flu tends to come on fast. You’ll typically feel symptoms one to four days after exposure, and the illness often hits like a wall: fine in the morning, miserable by evening. Most people recover within a week, though coughing and fatigue can linger for two weeks.
COVID-19 has a wider incubation window. Symptoms can appear anywhere from two to 14 days after exposure, with most people noticing them around day three to five. The illness also tends to follow a longer arc. Mild cases may last a week or so, but moderate cases often stretch to two weeks, and some people experience a pattern where symptoms improve briefly before worsening again around days seven through ten.
This difference in timeline matters for contagiousness, too. With the flu, you’re most contagious in the first three to four days of illness. With COVID-19, you can spread the virus for a longer window, and some people are contagious before symptoms even start.
COVID-19 Hits Harder on Average
A large study covering 2022 through 2024, examining 5.9 million people, found that hospitalization from COVID-19 was twice as likely as hospitalization from the flu. The death rate was three times higher. Among patients hospitalized during the winter months specifically, the risk of dying was still 23% higher from COVID-19 than from the flu. That gap widened for certain groups: unvaccinated people faced a 36% higher death risk from COVID compared to flu, and men and people with chronic health conditions also saw larger differences.
These numbers reflect a period well after the initial pandemic waves, when much of the population had some immunity from prior infection or vaccination. COVID-19’s severity advantage over the flu has narrowed since 2020, but it remains the more dangerous illness on a population level, particularly for adults 65 and older.
Risks for Children
Both viruses can cause severe illness in children, but they tend to attack differently. The flu primarily hits kids’ respiratory systems. COVID-19 can do the same, but it also carries a small risk of triggering multisystem inflammatory syndrome in children (MIS-C), a condition where multiple organ systems become inflamed weeks after the initial infection.
Children hospitalized with MIS-C typically have two body systems affected (for example, respiratory problems plus kidney involvement), compared to flu-hospitalized children who usually have one system affected. Hospital stays for MIS-C average about five days, versus two days for influenza. MIS-C has become rarer as population immunity has grown, but it remains a complication unique to COVID-19 with no real equivalent in seasonal flu.
What Happens After You Recover
One of the most significant differences between these two illnesses is what can happen in the months that follow. Research from Washington University found that COVID-19 increased the risk of 68% of health conditions examined across all organ systems (64 out of 94 adverse outcomes studied) in the 18 months after infection. The flu, by comparison, was linked to elevated risk of only 6% of those conditions, almost all in the respiratory system.
COVID-19 is more aggressive and less predictable in its long-term effects. It can cause lasting problems in the heart, brain, kidneys, and other organs, not just the lungs. The flu’s post-infection effects, sometimes called “long flu,” are real but tend to stay concentrated in the airways. There is one notable exception: the flu actually poses a higher long-term risk to the pulmonary system than COVID-19 does.
For both viruses, more than half of the total burden of death and disability occurred in the months after infection rather than during the initial acute illness. This means the first week or two of feeling sick is only part of the story.
Testing Is the Only Reliable Way to Tell
Because symptoms overlap so heavily, the only way to know which virus you have is to test. Combination tests now exist that can detect influenza A, influenza B, and COVID-19 from a single nasal swab. These multiplex tests are highly accurate during the acute phase of infection. Rapid home tests for COVID-19 are widely available, and some newer home tests screen for both viruses at once. If you’re in a high-risk group or your symptoms are worsening, knowing which virus you have matters because the treatments are different.
Treatments Work Differently
The flu is treated with antivirals that stop the virus from spreading between your cells. These work best when started within 48 hours of your first symptoms, which is a tight window. COVID-19 antivirals work by a different mechanism, blocking the virus from making copies of itself. The treatment window is more forgiving: up to five days from symptom onset.
Both sets of antivirals are oral medications (pills or capsules you take at home), and both are most commonly prescribed for people at higher risk of severe illness, such as older adults, immunocompromised individuals, or people with conditions like diabetes or heart disease. The key takeaway is that early testing leads to early treatment, and early treatment meaningfully reduces the chance of hospitalization with either virus.
Vaccines Use Different Approaches
Flu vaccines have relied on a decades-old process of growing viruses in fertilized chicken eggs, a technique first used in the 1940s. Because the flu mutates constantly and vaccine production is slow, scientists must predict months in advance which strains will circulate. This guessing game is a big reason why flu vaccine effectiveness has ranged from just 19% to 60% over the past 15 years.
COVID-19 vaccines introduced the mRNA platform to mainstream use, which allows manufacturers to design and produce vaccines much faster in response to new variants. This same technology is now being tested for flu vaccines, with early results showing mRNA-based flu shots preventing 60% to 67% of infections compared to 44% to 54% for conventional shots. Both COVID-19 and flu vaccines are updated regularly to match circulating strains, and you can receive both at the same visit.
The practical bottom line: vaccination for either virus reduces your risk of severe illness, hospitalization, and death, even when the vaccine isn’t a perfect match for the circulating strain. For both COVID-19 and the flu, unvaccinated individuals consistently face worse outcomes than vaccinated ones when hospitalized.